ArticleJournal of eating disorders2026
Lessons learned from a randomised controlled trial of a digital intervention targeting eating disorder symptoms in cisgender sexual minoritized men.
Article in Journal of eating disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundThere is an unmet need for evidence-based and accessible interventions designed to treat eating disorders in sexual minoritized men, given their heightened vulnerability to developing disordered eating. Digital interventions are a promising avenue for eating disorder treatment because of their accessibility and flexibility in delivery. Here, we present a randomised controlled trial of Seed, a 10-week treatment-focussed digital intervention for eating disorders, among sexual minoritized men.
methodsParticipants (N = 126 sexual minoritized men) with a binge-spectrum eating disorder diagnosis (e.g., bulimia nervosa, binge-eating disorder) were randomly allocated to one of three conditions: (1) a waitlist control (2) a personalised intervention, where participants received personalised content recommendations based on their individual symptom profile, or (3) a default intervention, in which participants received no personalised recommendations. Changes from baseline in eating disorder symptoms were evaluated via clinical interview and self-report at 10 week and 6 month follow up.
resultsRelative to the waitlist control and default conditions, participants in the personalised intervention condition reported significantly greater decreases in their global Eating Disorder Examination interview scores at post-intervention/10-week follow up. We did not observe any significant changes in self-reported eating disorder symptoms. Our results are tentative as we were underpowered to detect small-to-medium treatment effects.
conclusionsOur study provides preliminary evidence for the efficacy of Seed for treating eating disorders in sexual minoritized men, particularly when personalised content recommendations are provided. However, future research must provide greater quality evidence through well-powered, more rigorous clinical trials.
trial registrationThis trial was retrospectively registered on 04/03/2026 (Trial ID ACTRN12626000271303).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.